PRJNA754158 - Effective therapy of AML with RUNX1 mutation by co-treatment with inhibitors of protein translation and BCL2 [ATAC-seq] - OmicsDI

Genomics

Dataset Information

Effective therapy of AML with RUNX1 mutation by co-treatment with inhibitors of protein translation and BCL2 [ATAC-seq]

ABSTRACT: Effective therapy of AML with RUNX1 mutation by co-treatment with inhibitors of protein translation and BCL2 [ATAC-seq]

PROVIDER: PRJNA754158 | ENA |

REPOSITORIES: ENA

Dataset's files

Source:

			Action	DRS
	SRR15427806_1.fastq.gz	Fastqsanger.gz
	SRR15427806_2.fastq.gz	Fastqsanger.gz
	SRR15427807_1.fastq.gz	Fastqsanger.gz
	SRR15427807_2.fastq.gz	Fastqsanger.gz
	SRR15427808_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24